Developer docs
API playgroundTry for free, no card

Search company profiles

AUG Pharma

Full company profile

uuid000riqw

Namestring
AUG Pharma
Legal namestring
AUG Pharma
Websiteurl
augpharma.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

AUG Pharma is an Egyptian pharmaceutical manufacturing company founded in 2006 and headquartered in Gîza, Egypt, with 501–1,000 employees. The company manufactures and distributes a diversified portfolio of 58+ branded pharmaceutical products spanning dermatology (under the AUG-Derma sub-brand), nutritional supplements and immunity products (Sanso range), men's health (Dorectafil, DAPOXTARD), women's health (Sanso Folic, Sanso Hematinic), cardiovascular (Aspirin AUG-Pharma), anti-diabetic (DIBAVALLY PLUS), digestive system (ZURCAL, PROTOLANS, Pantoprazole Sala IV, G-SAC), orthopedic (Joint Care, Hot Strike Gel), and anti-inflammatory/analgesics (AUGCETAMIDE). The company operates its own manufacturing facility with pharmacovigilance and R&D functions, holds ISO 9001:2008 certification, and has obtained Saudi FDA (SFDA) approval enabling cross-border distribution.

AUG Pharma serves healthcare providers (physicians, dermatologists, pediatricians, gastroenterologists) and patients through a partner-driven, multi-channel distribution model. Primary GTM is event- and KOL-driven (active participation in conferences such as the Delta Union of Pediatrics Conference, Aswan Gastro Hub 2025, and PEACE Conference that drew 600+ dermatologists) combined with traditional pharmaceutical distribution channels in Egypt and a strategic partnership with Libyana for Libyan market entry. The company is led by CEO & President Dr. Ashraf Osman and Co-Founder & Country Director Ahmed Barakat, with no disclosed external investors or parent company. Revenue is generated through one-time product sales (physical pharmaceutical units) through wholesale/distribution intermediaries; pricing is not publicly disclosed. Strategic positioning targets affordable, high-quality medications across multiple therapeutic areas with an explicit MENA-region expansion thesis, evidenced by Libya market entry and SFDA approval.

Short descriptiontext

AUG Pharma is an Egyptian pharmaceutical manufacturer producing 58+ branded products across dermatology, supplements, cardiovascular, digestive, anti-diabetic, and men's/women's health, serving healthcare providers and patients in Egypt and expanding across the MENA region.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersGîza, Egypt
HQ citystring
Gîza
HQ countrystring
Egypt
HQ regionstring
Africa
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, dermatology products, nutritional supplements, men's health medications, digestive system drugs
Industry3 codes
PRIMARYHLAIABAD
Oral Solid Dose (OSD) Generics
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

AUG Pharma generates revenue through the manufacturing and sale of pharmaceutical products across multiple therapeutic categories including dermatology, pediatrics, digestive system, orthopedic, anti-inflammatory, cardiovascular, endocrine/diabetic, immunity, and women's/men's health.

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1AUG Derma
Description

Dermatology product line including moisturizers, sunscreen, and skincare treatments

augpharma.com
+2 more records
Core offering1 text field

AUG Pharma is an Egyptian pharmaceutical manufacturer that formulates, produces, and distributes a broad portfolio of finished dosage pharmaceutical products across multiple therapeutic categories including dermatology, cardiovascular, endocrine/diabetic, digestive system, orthopedic, anti-inflammatory/analgesics, men's health, women's health, pediatrics, and immunity. The company operates its own manufacturing facility in Egypt and sells branded product lines under the AUG-Pharma, AUG Derma, and Sanso sub-brands.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

AUG Pharma is an Egyptian pharmaceutical company with a diverse portfolio of over 58 products spanning multiple therapeutic categories. The product portfolio includes: dermatology products under the AUG-Derma sub-brand (Urea Complete Repair Cream, Vaseline Cream, Panthenol, Brucare, Silicon Gel, Baby Cream with Aloe-Vera, Sunscreen); the Sanso Range of nutritional supplements including collagen-based skincare products (Collagen Cream, Collagen Cleansing Gel, Hyaluronic Acid + Vitamin C Serum), immunity products (Sanso Immune, Sanso Immune Plus, Sanso C Plus), vitamin supplements (SANSOVIT Iron, SANSOVIT MultiVitamin, Sanso Lactoferrin), and mineral supplements (Sansocal-D, Sanso D3, Sanso D3 Plus, Sanso Magnesium); women's health products (Sanso Folic, Sanso Hematinic); men's health products (Dorectafil for erectile dysfunction, DAPOXTARD for premature ejaculation); cardiovascular products (Aspirin AUG-Pharma); anti-diabetic products (DIBAVALLY PLUS); digestive system products (ZURCAL, PROTOLANS, Pantoprazole Sala IV, G-SAC); orthopedic products (Joint Care, JointCare Plus, Hot strike Gel, Ibuprosol Topical Gel, NOXILORN); anti-inflammatory analgesics (AUGCETAMIDE); and other products including Faktu Rectal Suppository and Lactulose AUG-Pharma. The company operates its own manufacturing facility and has achieved international certifications including ISO 9001:2008 quality management system.

Product and service2 records
1AUG Derma
CategoryDermatology Pharmaceuticals
Description

Dermatology product line covering skin moisturizing, sun protection, scar treatment, baby care, and skin healing formulations for patients and healthcare providers.

2Sanso Range
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-05-06
Description

AUG Pharma entered into a strategic collaboration with Libyana for importing pharmaceutical and medical equipment as part of their expansion into the Libyan market. The partnership aligns with AUG Pharma's vision to expand across the MENA region and enhance access to essential medications. Initial portfolio includes treatments for chronic diseases, infections, and cardiovascular conditions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company shown on AUG Pharma's partner section of the website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company shown on AUG Pharma's partner section of the website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner company shown on AUG Pharma's partner section of the website.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Julphar (Gulf Pharmaceutical Industries)
TypeRegional player
Description

UAE-based MENA pharmaceutical manufacturer with branded generics across multiple therapeutic areas; comparable in product mix and regional GCC/MENA focus, though headquartered in a different GCC market.

TypeRegional player
Description

Saudi-based pharmaceutical manufacturer producing branded generics across multiple therapeutic categories with MENA distribution; a relevant comparable for AUG Pharma's Saudi expansion strategy.

TypeDirect peer
Description

Egyptian pharmaceutical manufacturer with broad therapeutic portfolio and MENA/Africa export presence; the closest direct competitor in scale, product mix, and Egypt-based manufacturing footprint.

TypeDirect peer
Description

Major Egyptian generic and specialty pharmaceutical manufacturer with a wide therapeutic portfolio and MENA/Africa exports; directly comparable in product categories, manufacturing scope and regional market focus.

5Marcyrl Pharmaceutical Industries
TypeDirect peer
Description

Egyptian pharmaceutical manufacturer with a diversified portfolio of branded generics across cardiovascular, anti-infective and other therapeutic areas; comparable in scale, manufacturing model and regional ambition.

TypeDirect peer
Description

Egypt-based pharmaceutical manufacturer producing branded generics and OTC products across multiple therapeutic areas; directly comparable in business model and target markets.

TypeDirect peer
Description

One of Egypt's largest pharmaceutical manufacturers producing branded generics across multiple therapeutic categories, with regional MENA distribution; directly comparable in business model and customer base.

TypeEmerging player
Description

Egypt-based pharmaceutical manufacturer focused on specialty and branded generics; smaller in scale but comparable in product categories and Egypt/MENA go-to-market approach.

TypeBroad incumbent
Description

Leading MENA-headquartered (Jordan) generic and specialty pharmaceutical company with manufacturing in MENA and US; broader scale but overlapping product categories (cardiovascular, anti-infective, oncology) and target markets.

TypeRegional player
Description

Saudi-listed pharmaceutical manufacturer with branded generics and licensing partnerships; the principal local incumbent in AUG Pharma's targeted Saudi market, comparable in generic business model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AUG Pharma

Pharmaceutical Manufacturingaugpharma.com

AUG Pharma is an Egyptian pharmaceutical manufacturer producing 58+ branded products across dermatology, supplements, cardiovascular, digestive, anti-diabetic, and men's/women's health, serving healthcare providers and patients in Egypt and expanding across the MENA region.

What AUG Pharma does

AUG Pharma is an Egyptian pharmaceutical manufacturing company founded in 2006 and headquartered in Gîza, Egypt, with 501–1,000 employees. The company manufactures and distributes a diversified portfolio of 58+ branded pharmaceutical products spanning dermatology (under the AUG-Derma sub-brand), nutritional supplements and immunity products (Sanso range), men's health (Dorectafil, DAPOXTARD), women's health (Sanso Folic, Sanso Hematinic), cardiovascular (Aspirin AUG-Pharma), anti-diabetic (DIBAVALLY PLUS), digestive system (ZURCAL, PROTOLANS, Pantoprazole Sala IV, G-SAC), orthopedic (Joint Care, Hot Strike Gel), and anti-inflammatory/analgesics (AUGCETAMIDE). The company operates its own manufacturing facility with pharmacovigilance and R&D functions, holds ISO 9001:2008 certification, and has obtained Saudi FDA (SFDA) approval enabling cross-border distribution.

AUG Pharma serves healthcare providers (physicians, dermatologists, pediatricians, gastroenterologists) and patients through a partner-driven, multi-channel distribution model. Primary GTM is event- and KOL-driven (active participation in conferences such as the Delta Union of Pediatrics Conference, Aswan Gastro Hub 2025, and PEACE Conference that drew 600+ dermatologists) combined with traditional pharmaceutical distribution channels in Egypt and a strategic partnership with Libyana for Libyan market entry. The company is led by CEO & President Dr. Ashraf Osman and Co-Founder & Country Director Ahmed Barakat, with no disclosed external investors or parent company. Revenue is generated through one-time product sales (physical pharmaceutical units) through wholesale/distribution intermediaries; pricing is not publicly disclosed. Strategic positioning targets affordable, high-quality medications across multiple therapeutic areas with an explicit MENA-region expansion thesis, evidenced by Libya market entry and SFDA approval.

AUG Pharma firmographics

Firmographics
Name
AUG Pharma
Legal name
AUG Pharma
Website
https://augpharma.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
501–1,000 employees
Short description
AUG Pharma is an Egyptian pharmaceutical manufacturer producing 58+ branded products across dermatology, supplements, cardiovascular, digestive, anti-diabetic, and men's/women's health, serving healthcare providers and patients in Egypt and expanding across the MENA region.
Ownership category
akta.pro rank

AUG Pharma industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAD
Oral Solid Dose (OSD) Generics
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical manufacturing
  • Dermatology products
  • Nutritional supplements
  • Men's health medications
  • Digestive system drugs

Where AUG Pharma is headquartered

Location

Headquarters

HQ city
Gîza
HQ country
Egypt
HQ region
Africa

Offices1 record

Markets served

AUG Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: AUG Pharma generates revenue through the manufacturing and sale of pharmaceutical products across multiple therapeutic categories including dermatology, pediatrics, digestive system, orthopedic, anti-inflammatory, cardiovascular, endocrine/diabetic, immunity, and women's/men's health.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

AUG Pharma product offering

Product offering

Core offering

AUG Pharma is an Egyptian pharmaceutical manufacturer that formulates, produces, and distributes a broad portfolio of finished dosage pharmaceutical products across multiple therapeutic categories including dermatology, cardiovascular, endocrine/diabetic, digestive system, orthopedic, anti-inflammatory/analgesics, men's health, women's health, pediatrics, and immunity. The company operates its own manufacturing facility in Egypt and sells branded product lines under the AUG-Pharma, AUG Derma, and Sanso sub-brands.

Product overview

AUG Pharma is an Egyptian pharmaceutical company with a diverse portfolio of over 58 products spanning multiple therapeutic categories. The product portfolio includes: dermatology products under the AUG-Derma sub-brand (Urea Complete Repair Cream, Vaseline Cream, Panthenol, Brucare, Silicon Gel, Baby Cream with Aloe-Vera, Sunscreen); the Sanso Range of nutritional supplements including collagen-based skincare products (Collagen Cream, Collagen Cleansing Gel, Hyaluronic Acid + Vitamin C Serum), immunity products (Sanso Immune, Sanso Immune Plus, Sanso C Plus), vitamin supplements (SANSOVIT Iron, SANSOVIT MultiVitamin, Sanso Lactoferrin), and mineral supplements (Sansocal-D, Sanso D3, Sanso D3 Plus, Sanso Magnesium); women's health products (Sanso Folic, Sanso Hematinic); men's health products (Dorectafil for erectile dysfunction, DAPOXTARD for premature ejaculation); cardiovascular products (Aspirin AUG-Pharma); anti-diabetic products (DIBAVALLY PLUS); digestive system products (ZURCAL, PROTOLANS, Pantoprazole Sala IV, G-SAC); orthopedic products (Joint Care, JointCare Plus, Hot strike Gel, Ibuprosol Topical Gel, NOXILORN); anti-inflammatory analgesics (AUGCETAMIDE); and other products including Faktu Rectal Suppository and Lactulose AUG-Pharma. The company operates its own manufacturing facility and has achieved international certifications including ISO 9001:2008 quality management system.

Differentiator

Problem solved

Functional benefit

Brands

  • AUG Derma: Dermatology product line including moisturizers, sunscreen, and skincare treatments
  • Sanso
  • AUG-Pharma

Products and services

  • AUG Derma Dermatology product line covering skin moisturizing, sun protection, scar treatment, baby care, and skin healing formulations for patients and healthcare providers.
  • Sanso Range

Companies that use AUG Pharma

Customer profile

Named customers12 records

Segments1 record

Ideal customer profiles1 record

AUG Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AUG Pharma partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • LibyanacoreChannel Partner/ Reseller/ Distributor · 6 May 2025AUG Pharma entered into a strategic collaboration with Libyana for importing pharmaceutical and medical equipment as part of their expansion into the Libyan market. The partnership aligns with AUG Pharma's vision to expand across the MENA region and enhance access to essential medications. Initial portfolio includes treatments for chronic diseases, infections, and cardiovascular conditions.
  • VitafoodsminorStrategic or Co-development PartnerPartner company shown on AUG Pharma's partner section of the website.
  • PharmathlenminorStrategic or Co-development PartnerPartner company shown on AUG Pharma's partner section of the website.
  • Cigalah Medical IndustriesminorStrategic or Co-development PartnerPartner company shown on AUG Pharma's partner section of the website.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

AUG Pharma competitors and assessment

Company assessment

Regional players

  • Julphar (Gulf Pharmaceutical Industries): UAE-based MENA pharmaceutical manufacturer with branded generics across multiple therapeutic areas; comparable in product mix and regional GCC/MENA focus, though headquartered in a different GCC market.
  • Tabuk Pharmaceuticals: Saudi-based pharmaceutical manufacturer producing branded generics across multiple therapeutic categories with MENA distribution; a relevant comparable for AUG Pharma's Saudi expansion strategy.
  • SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi-listed pharmaceutical manufacturer with branded generics and licensing partnerships; the principal local incumbent in AUG Pharma's targeted Saudi market, comparable in generic business model.

Direct peers

  • Eva Pharma: Egyptian pharmaceutical manufacturer with broad therapeutic portfolio and MENA/Africa export presence; the closest direct competitor in scale, product mix, and Egypt-based manufacturing footprint.
  • EIPICO (Egyptian International Pharmaceutical Industries): Major Egyptian generic and specialty pharmaceutical manufacturer with a wide therapeutic portfolio and MENA/Africa exports; directly comparable in product categories, manufacturing scope and regional market focus.
  • Marcyrl Pharmaceutical Industries: Egyptian pharmaceutical manufacturer with a diversified portfolio of branded generics across cardiovascular, anti-infective and other therapeutic areas; comparable in scale, manufacturing model and regional ambition.
  • Amoun Pharmaceutical: Egypt-based pharmaceutical manufacturer producing branded generics and OTC products across multiple therapeutic areas; directly comparable in business model and target markets.
  • Pharco Pharmaceuticals: One of Egypt's largest pharmaceutical manufacturers producing branded generics across multiple therapeutic categories, with regional MENA distribution; directly comparable in business model and customer base.

Emerging players

  • Mepaco Pharma: Egypt-based pharmaceutical manufacturer focused on specialty and branded generics; smaller in scale but comparable in product categories and Egypt/MENA go-to-market approach.

Broad incumbents

  • Hikma Pharmaceuticals: Leading MENA-headquartered (Jordan) generic and specialty pharmaceutical company with manufacturing in MENA and US; broader scale but overlapping product categories (cardiovascular, anti-infective, oncology) and target markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

AUG Pharma social profiles

Digital presence

AUG Pharma compliance and trust

Trust signal

Compliance1 record

AUG Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AUG Pharma leadership team

Management profile

Number of profiles

Profiles1 record

AUG Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AUG Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AUG Pharma

What does AUG Pharma do?

AUG Pharma is an Egyptian pharmaceutical manufacturer that formulates, produces, and distributes a broad portfolio of finished dosage pharmaceutical products across multiple therapeutic categories including dermatology, cardiovascular, endocrine/diabetic, digestive system, orthopedic, anti-inflammatory/analgesics, men's health, women's health, pediatrics, and immunity. The company operates its own manufacturing facility in Egypt and sells branded product lines under the AUG-Pharma, AUG Derma, and Sanso sub-brands.

Is AUG Pharma a public or private company?

AUG Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AUG Pharma founded?

AUG Pharma was founded in 2006. It employs 501 to 1,000 people.

Where is AUG Pharma based?

AUG Pharma is headquartered in Gîza, Egypt, in the Africa region.

How does AUG Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are AUG Pharma's main competitors?

Regional players on record are Julphar (Gulf Pharmaceutical Industries), Tabuk Pharmaceuticals and SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances). Direct peers are Eva Pharma, EIPICO (Egyptian International Pharmaceutical Industries), Marcyrl Pharmaceutical Industries, Amoun Pharmaceutical and Pharco Pharmaceuticals. Mepaco Pharma is listed as an emerging player. Hikma Pharmaceuticals is listed as a broad incumbent.

Does AUG Pharma have an API?

No public API is recorded for AUG Pharma.

What industry is AUG Pharma in?

AUG Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAD, Oral Solid Dose (OSD) Generics, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales